Effects of the intravenous administration of magnesium sulfate on corrected serum calcium level and nephrogenous cyclic AMP excretion in normal human subjects. 1986

K Suzuki, and K Nonaka, and N Kono, and K Ichihara, and Y Fukumoto, and Y Inui, and J Miyagawa, and T Onishi, and C Hayashi, and S Tarui

The effect of intravenous magnesium sulfate infusion on corrected serum calcium level and parathyroid function assessed by determination of nephrogenous cAMP (NcAMP) excretion were studied in normal human subjects. Significant hypermagnesemia induced by the magnesium sulfate infusion for 120 minutes was accompanied by a gradual and progressive decrease in the corrected serum calcium level. NcAMP excretion fell rapidly, reaching a nadir between 60 and 120 minutes after the infusion began, and after that rose above the baseline excretion. Urinary calcium excretion gradually increased, reaching a peak between 120 and 180 minutes after the infusion began and then gradually decreased. Since magnesium was given as the sulfate, it is not clear whether these changes were attributable to magnesium or sulfate or both. As a control study, we performed intravenous sodium sulfate infusion. The sodium sulfate infusion caused slight hypocalcemia, slight hypercalciuria, and a significant increase in NcAMP excretion. These findings indicate that the hypocalcemia and the hypercalciuria caused by the magnesium sulfate infusion is mainly due to the effect of magnesium, and that the decrease in NcAMP excretion during the infusion is due to the effect of magnesium alone. We conclude that the hypocalcemia caused by the magnesium sulfate infusion is mainly due to the renal calcium loss, and that the inhibition of parathyroid function caused by hypermagnesemia may be only partially involved in the early phase of this hypocalcemia.

UI MeSH Term Description Entries
D006996 Hypocalcemia Reduction of the blood calcium below normal. Manifestations include hyperactive deep tendon reflexes, Chvostek's sign, muscle and abdominal cramps, and carpopedal spasm. (Dorland, 27th ed) Hypocalcemias
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008274 Magnesium A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.
D008278 Magnesium Sulfate A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083) Magnesium Sulfate, Heptahydrate,Heptahydrate Magnesium Sulfate,Sulfate, Magnesium
D008297 Male Males
D010280 Parathyroid Glands Two pairs of small oval-shaped glands located in the front and the base of the NECK and adjacent to the two lobes of THYROID GLAND. They secrete PARATHYROID HORMONE that regulates the balance of CALCIUM; PHOSPHORUS; and MAGNESIUM in the body. Gland, Parathyroid,Glands, Parathyroid,Parathyroid Gland
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic

Related Publications

K Suzuki, and K Nonaka, and N Kono, and K Ichihara, and Y Fukumoto, and Y Inui, and J Miyagawa, and T Onishi, and C Hayashi, and S Tarui
April 1984, Scandinavian journal of clinical and laboratory investigation,
K Suzuki, and K Nonaka, and N Kono, and K Ichihara, and Y Fukumoto, and Y Inui, and J Miyagawa, and T Onishi, and C Hayashi, and S Tarui
March 1978, The Journal of clinical endocrinology and metabolism,
K Suzuki, and K Nonaka, and N Kono, and K Ichihara, and Y Fukumoto, and Y Inui, and J Miyagawa, and T Onishi, and C Hayashi, and S Tarui
January 1984, Mineral and electrolyte metabolism,
K Suzuki, and K Nonaka, and N Kono, and K Ichihara, and Y Fukumoto, and Y Inui, and J Miyagawa, and T Onishi, and C Hayashi, and S Tarui
August 1984, Acta endocrinologica,
K Suzuki, and K Nonaka, and N Kono, and K Ichihara, and Y Fukumoto, and Y Inui, and J Miyagawa, and T Onishi, and C Hayashi, and S Tarui
July 1988, Nihon Naibunpi Gakkai zasshi,
K Suzuki, and K Nonaka, and N Kono, and K Ichihara, and Y Fukumoto, and Y Inui, and J Miyagawa, and T Onishi, and C Hayashi, and S Tarui
December 1966, The Journal of pharmacology and experimental therapeutics,
K Suzuki, and K Nonaka, and N Kono, and K Ichihara, and Y Fukumoto, and Y Inui, and J Miyagawa, and T Onishi, and C Hayashi, and S Tarui
August 1976, The Journal of clinical investigation,
K Suzuki, and K Nonaka, and N Kono, and K Ichihara, and Y Fukumoto, and Y Inui, and J Miyagawa, and T Onishi, and C Hayashi, and S Tarui
January 1990, Polski tygodnik lekarski (Warsaw, Poland : 1960),
K Suzuki, and K Nonaka, and N Kono, and K Ichihara, and Y Fukumoto, and Y Inui, and J Miyagawa, and T Onishi, and C Hayashi, and S Tarui
June 1988, The American journal of clinical nutrition,
K Suzuki, and K Nonaka, and N Kono, and K Ichihara, and Y Fukumoto, and Y Inui, and J Miyagawa, and T Onishi, and C Hayashi, and S Tarui
July 1988, Bone and mineral,
Copied contents to your clipboard!